Global Closed System Transfer Devices (CSTD) Market Key Insights
During the forecast period of 2023-2035, the global closed system transfer devices (CSTD) market is expected to reach an estimated value of ~USD 3500 million by 2035 by expanding at a CAGR of ~15%. The market further generated revenue of ~USD 800 million in the year 2022. Major key factors propelling the growth of the closed system transfer devices (CSTD) market are the higher utilization of closed system transfer devices to deliver antineoplastic drugs in the chemotherapy to treat the symptoms of cancer and the rising prevalence of cancer.
Market Definition of Closed System Transfer Devices (CSTD)
Closed system transfer devices (CSTD) is a system to reduce the risk of drug aerosols during the transfer of medication from one point to another. It also minimizes the risk of sharp exposure, and hazardous drug exposure and contamination. Closed-system transfer devices are used to eliminate the transfer of environmental contaminants. These devices generally come in a few design concepts that use sir-cleaning technology or physical barrier to prevent the mix of harmful drugs in the work environment.
Get a Sample PDF Brochure: https://www.researchnester.com/sample-request-4090
Global Closed System Transfer Devices (CSTD) Market: Growth Drivers
The growth of the global closed system transfer devices (CSTD) market can majorly be attributed to the rising prevalence of urinary tract infections and pneumonia to need the administration of antibiotics to cure the symptoms. Pneumonia is common in children and they cannot swallow antibiotics where the administration through CSTDs becomes necessary. For instance, the annual rate of death caused by pneumonia in America is estimated to be around 45000 while approximately 1 million adults suffer from it every year. On the other hand, a higher adoption rate of closed system transfer devices to avoid the side effects of chemo drugs such as, infertility, kidney and liver damage, and others are estimated to fuel the market growth during the forecast period. For instance, it was estimated that nearly 22% of acute renal infections are caused by medicinal drugs.
The global closed system transfer devices (CSTD) market is also estimated to grow majorly on account of the following:
• Increasing number of chemotherapy boosting the demand for antineoplastic drugs
• Rising prevalence of cancer
• Growth in the adoption of closed-system transfer devices
• Complexity in the oral administration of certain drugs
• Technological advancement in the field of medicinal drugs
Request for customization @ https://www.researchnester.com/customized-reports-4090
Global Closed System Transfer Devices (CSTD) Market: Restraining Factor
There is a high possibility of drug leakage during the administration that can negatively impact the health of the healthcare provider. Hence this factor is expected to be the major hindrance for the growth of the global closed system transfer devices (CSTD) market during the forecast period.
Global Closed System Transfer Devices (CSTD) Market Segmentation
• By Type (Membrane-to-Membrane and Needleless)
The membrane-to-membrane segment, amongst all the other segments, is anticipated to garner the largest revenue by the end of 2035. The growth of the segment can be attributed to the fact that this type has the lowest rate of risk of contamination since it also comprises a double-membrane containment system. Drug contamination can cause many types of infections such as, hepatitis C, HIV, and others. It is estimated that approximately 1.4 million new infections of hepatitis C occur every year.
• By Technology (Diaphragm, Compartmentalized, Filtration, Others)
• By End-User (Hospitals & Clinics, Oncology Centers, and Others)
• By Region
The Asia Pacific closed system transfer devices (CSTD) market is anticipated to hold the largest market share by the end of 2035 among the market in all the other regions. The surge in the cases of cancer in the region and growing awareness of the early diagnosis of this disease leading to the high requirement of chemotherapy is estimated to expand the market size over the forecast period. It was noted in 2018, nearly 5 million deaths were accounted to cancer while 8 million new cases of cancer were diagnosed in the same year.
Obtain this Report @ https://www.researchnester.com/reports/closed-system-transfer-devices-cstd-market/4090
The market research report on global closed system transfer devices (CSTD) also includes the market size, market revenue, Y-o-Y growth, and key player analysis applicable for the market in North America (U.S., and Canada), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), and Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa).

Key Market Players Featured in the Global Closed System Transfer Devices (CSTD) Market
Some of the key players of the global closed system transfer devices (CSTD) market are Becton, Dickinson and Company, B. Braun Melsungen AG, ICU Medical, Inc., Equashield, LLC, CODAN Medizinische Geräte GmbH & Co KG, Simplivia Healthcare Ltd., Corvida Medical, Inc., Caragen Ltd., Baxter International Inc., Pfizer Inc., and others.
About Research Nester
Research Nester, which is a leading service provider for strategic market research and consulting services, aims to provide unbiased, unparalleled market insights and industry analysis. These analyses help conglomerates, executives, and industries to take wise decisions for their businesses as well as for their future marketing strategy, expansion and investment among others. We believe that our expertise in the field of market research can help businesses to expand to its new horizon. Our team of research analysts can provide businesses a right guidance at the right time, while our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.
Contact for more Info:
AJ Daniel
Email: [email protected]
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919